Teladoc Health delivered Q4 2025 revenue of $642.3 million, which was flat year-over-year, while adjusted EBITDA grew 12% to $83.8 million. The company saw a significant narrowing of its net loss compared to the prior year, driven by growth in the Integrated Care segment and international markets, despite a decline in BetterHelp revenue.
Q4 revenue of $642.3 million was flat year-over-year, beating the midpoint of guidance.
Adjusted EBITDA increased 12% to $83.8 million, reflecting improved operational efficiency.
International revenue grew 19% year-over-year, offsetting a 3% decline in U.S. revenue.
The BetterHelp segment continues to face headwinds with revenue declining 7% and adjusted EBITDA down 15%.
For the full year 2026, Teladoc expects revenue between $2.47 billion and $2.587 billion, with a focus on Integrated Care growth and stabilizing BetterHelp margins.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance